Inside biotech news website of Europe

Inside Labiotech 21 Dec 2017

How Labiotech is Surfing on the Digital Media Revolution

Media was the first industry to be disrupted by the digital revolution, aka “The Internet”. Most of the established media platforms are still trying to figure out what to do, especially on the revenues/profits side of things. On the other hand, some of the biggest players today were founded in the last 15 years, think […]

December 21, 2017 - 6 minutesmins - By Philip Hemme

Inside Labiotech 30 Nov 2017

Why is Erik Digman Wiklund, CFO of Targovax, reading Labiotech.eu?

Leaders & Readers: I had a chat with Erik Digman Wiklund about why he reads Labiotech.eu. He is the CFO of Targovax, a clinical-stage company focusing on the development of immuno-oncology therapies. This interview has just been lightly edited for grammar. Why do you read Labiotech.eu? I enjoy the easygoing and fun style of Labiotech, which […]

November 30, 2017 - 2 minutesmins - By Katherine Douglas

Inside Labiotech 23 Nov 2017

Labiotech’s Identity Gets a Makeover

You may have noticed Labiotech has been changing it up a bit, adding a splash of paint and a curvy line here or there. Well, we decided it’s high time we improved our graphic identity. Alfredo has been the mastermind behind these new changes. He has recently joined us from Italy and has been doing […]

November 23, 2017 - 2 minutesmins - By Katherine Douglas

Inside Labiotech 28 Sep 2017

Why does Labiotech.eu exist? (Not only to play table football together)

Our mission, since we started Labiotech.eu, has been to empower biotech ecosystems to better cure, feed and fuel the world. In our team, we all believe biotech is an industry that has an enormous impact on making the world a better place (I can’t actually think of any more impactful industry). Bill Gates recently told […]

September 28, 2017 - 3 minutesmins - By Philip Hemme

Inside Labiotech 21 Sep 2017

How we raised our second financing round? (Yes, it was tough)

You might have seen our press release or read about it on other media outlets, such as Tech.eu, EU-Startups, Gruenderszene.de, VC-Magazin, Deutsche-startups.de or Wan-Ifra: we just raised our second financing round. It’s a major milestone for the development of Labiotech.eu as it will allow us to continue investing in amazing content, launch new products and […]

September 21, 2017 - 6 minutesmins - By Philip Hemme

Inside Labiotech 18 Sep 2017

Press Release: We raised our second financing round to become the largest biotech media 🚀

Happy news to announce this morning: we just closed our second fundraising from new and existing investors 😉👌 It’s a major milestone for the development of Labiotech.eu as it will allow us to continue investing in amazing content, launch new products and grow our revenues. Thanks to the team for their amazing work and for making […]

September 18, 2017 - 3 minutesmins - By Philip Hemme

Inside Labiotech 30 Jun 2017

Infographic: Labiotech’s Story in a Line 😉

We will keep growing and having fun for many years! When we look back, we can proudly see how much we have achieved during these years. Today, we are excited to share with all our storyline, with the most special moments. Some of you know us from the beginning (hi dad and mom), but many only know […]

June 30, 2017 - 1 minutemin - By Editorial Team

Inside Labiotech 27 Apr 2017

Wait but why is Labiotech.eu based in Berlin?

After “How do you make money,” that’s the question I am asked most. Here’s the answer for all the curious people out there! As you might already know, Labiotech.eu started in France. I was studying bioengineering with Joachim (the first guy I talked to on the first day of the first year!) at Sup’Biotech, and […]

April 27, 2017 - 4 minutesmins - By Philip Hemme

Inside Labiotech 14 Apr 2017

Why is Ingmar Hoerr, Co-Founder & CEO of CureVac, reading Labiotech.eu?

Leaders & Readers: I had a chat with Ingmar Hoerr about why he reads Labiotech.eu. He is the co-founder and CEO of CureVac, one of the most successful European biotechs. This interview has just been lightly edited for grammar. Why do you read Labiotech.eu, and how does it help you in your job? I really like the […]

April 14, 2017 - 2 minutesmins - By Editorial Team

Inside Labiotech 17 Mar 2017

Why is Sofinnova’s Rafaèle Tordjman reading Labiotech.eu?

In our new series, “Leaders & Readers,” we ask different European biotech leaders to tell us why they read Labiotech.eu. This time, we talked to Rafaèle Tordjman, now Special Advisor at Sofinnova Partners, one of the most successful European biotech VCs. This interview has just been lightly edited for grammar. Why do you read Labiotech.eu? Labiotech.eu is very interesting, […]

March 17, 2017 - 2 minutesmins - By Editorial Team

Inside Labiotech 13 Jan 2017

Never lazy, baby! That’s what we achieved in 2016!

Bonjour to all our readers! I hope you started the new year happily and that, after all that Christmas holiday coziness, your way back into work was not too harsh! The Labiotech team is back again, too, with more optimism and vigour than ever! We took the stock of last year’s achievements and want to share with […]

January 13, 2017 - 2 minutesmins - By Philip Hemme

Inside Labiotech 28 Oct 2016

Santé, Labiotech.eu is now 2 years old! (and what a journey so far)

Yes, it’s been already 2 years since Joachim and I moved to Berlin to work full-time on changing the media landscape of Biotech. And this second year has just been exceptional: we are now the leading digital media in Europe with 50k monthly visitors, a team of almost 10 people, solid investors, and over 50 customers. […]

October 28, 2016 - 5 minutesmins - By Philip Hemme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us